A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M.
Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
2012
ISSN/ISBN: 1525-4135 Document Number: 259368
Document emailed within 1 workday
Related Documents
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157Sulaiman, M.M.; Shettima, J.; Ummate, I.; Arogundade, F.A.; Yusuph, H.; Nwankwo, E.; Sanusi, A.A.; Akinsola, A. 2022: Comparative Evaluation of Prevalence, Risk Factors, and Pathologic Features of Kidney Disease in Highly Active Antiretroviral Therapy-Naive and Highly Active Antiretroviral Therapy-Experienced Patients at a Tertiary Health Facility in Maiduguri, Northeastern Nigeria Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 33(1): 72-79
Hengge, U.R.; Goos, M.; Esser, S.; Exner, V.; Dötterer, H.; Wiehler, H.; Borchard, C.; Müller, K.; Beckmann, A.; Eppner, M.T.; Berger, A.; Fiedler, M. 1998: Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients Aids 12(17): F225-F234
Tan, R.; Westfall, A.O.; Willig, J.H.; Mugavero, M.J.; Saag, M.S.; Kaslow, R.A.; Kempf, M.C. 2008: Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 47(5): 553-558
Firnhaber, C.; Westreich, D.; Schulze, D.; Williams, S.; Siminya, M.; Michelow, P.; Levin, S.; Faesen, M.; Smith, J.S. 2012: Highly active antiretroviral therapy and cervical dysplasia in HIV-positive women in South Africa Journal of the International Aids Society 15(2): 17382
Nguemaïm, N.F.; Mbuagbaw, J.; Nkoa, T.; Alemnji, G.; Této, G.; Fanhi, T.C.; Asonganyi, T.; Samé-Ekobo, A. 2010: Serum lipid profile in highly active antiretroviral therapy-naïve HIV-infected patients in Cameroon: a case-control study HIV Medicine 11(6): 353-359
Kakinami, L.; de Bruyn, G.; Pronyk, P.; Mohapi, L.; Tshabangu, N.; Moshabela, M.; McIntyre, J.; Martinson, N.A. 2011: The impact of highly active antiretroviral therapy on activities of daily living in HIV-infected adults in South Africa Aids and Behavior 15(4): 823-831
Palacios, R.; Merchante, N.ás.; Macias, J.; González, M.; Castillo, J.ús.; Ruiz, J.; Márquez, M.; Gómez-Mateos, J.ús.; Pineda, J.A.; Santos, J.ús. 2006: Incidence of and risk factors for insulin resistance in treatment-naive HIV-infected patients 48 weeks after starting highly active antiretroviral therapy Antiviral Therapy 11(4): 529-535
Ni, L.; Wang, R-Bing.; Guo, H-Jun.; Tan, X-Hua.; Sun, L-Jun.; Zheng, Y-Huang.; Duan, C-Yu.; Hu, D-Qing.; Wang, W-Jing.; Wang, Y-Guang.; Zhao, H-Xin. 2013: Multi-centered, randomized controlled clinical study on Chinese medicine formula particles for hyperlipidaemia associated with highly active antiretroviral therapy Zhongguo Zhong Yao Za Zhi 38(15): 2443-2447
Pomerantz, R.J. 1999: HIV patients receiving HAART therapy can still transmit the virus. Highly active antiretroviral chemotherapy American Family Physician 59(10): 2855
Maharaj, S.S.; Chetty, V. 2011: Rehabilitation program for the quality of life for individuals on highly active antiretroviral therapy in KwaZulu-Natal, South Africa: a short report International Journal of Rehabilitation Research. Internationale Zeitschrift für Rehabilitationsforschung. Revue Internationale de Recherches de Readaptation 34(4): 360-365
Kaye, D.K.; Kakaire, O.; Osinde, M.O.; Lule, J.C.; Kakande, N. 2013: The impact of highly active antiretroviral therapy on high-risk behaviour of HIV-infected patients in sub-Saharan Africa Journal of Infection in Developing Countries 7(6): 436-447
Ikpeme, E.E.; Etukudo, O.M.; Ekrikpo, U.E. 2013: Seroprevalence of HBV and HIV co-infection in children and outcomes following highly active antiretroviral therapy (HAART) in Uyo, South-South Nigeria African Health Sciences 13(4): 955-961
Idiculla, J. 2011: Anthropometric changes in patients receiving highly active antiretroviral therapy (ART) Journal of the Association of Physicians of India 59: 530; Author Reply 530
Deng, X.-j.; He, Y.; Yang, L.; Zou, S.-p.; Yang, H.; Zheng, Y.-h. 2011: The evaluation of four-year highly active antiretroviral therapy in HIV-1 infected patients Zhonghua Nei Ke Za Zhi 50(3): 230-234
Vibhagool, A.; Sungkanuparph, S.; Mootsikapun, P.; Chetchotisakd, P.; Tansuphaswaswadikul, S.; Bowonwatanuwong, C.; Ingsathit, A. 2003: Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 36(10): 1329-1331
Farrant, L.; Gwyther, L.; Dinat, N.; Mmoledi, K.; Hatta, N.; Harding, R. 2012: The prevalence and burden of pain and other symptoms among South Africans attending highly active antiretroviral therapy (HAART) clinics South African Medical Journal 102(6): 499-500
Luo, J.; Jing, D.; Kozak, I.; Huiming, Z.; Siying, C.; Yezhen, Y.; Xin, Q.; Luosheng, T.; Adelman, R.A.; Forster, S.H. 2013: Prevalence of ocular manifestations of HIV/AIDS in the highly active antiretroviral therapy (HAART) era: a different spectrum in Central South China Ophthalmic Epidemiology 20(3): 170-175
Fox, R.; Gourlay, Y.J. 2000: The impact of highly active antiretroviral combination therapy in HIV infected patients in Glasgow Health Bulletin 58(4): 309-315
Pinto, J.L.; López Lavid, C.; Badia, X.; Coma, A.; Benavides, A. 2000: Cost effectiveness analysis of highly active antiretroviral therapy in HIV asymptomatic patients Medicina Clinica 114(Suppl 3): 62-67